KMRC011: Clinical Trials

1 trial of KMRC011, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow KMRC011: new trials by email Literature Review of KMRC011 trials Research Report on KMRC011

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011
KMRC011 5μg or Placebo, KMRC011 10μg or Placebo, KMRC011 15μg or Placebo - Acute Radiation Syndrome
Phase 1CompletedIntron Biotechnology, Inc.262018-06-112021-02-01

Conditions studied

Acute Radiation Syndrome (1)

Sponsors

Intron Biotechnology, Inc. (1)

Countries

South Korea (1)

Top investigators

Jung-Ryul Kim, MD, PhD (1)